Colony Group’s Abiomed Inc ABMD Stock Holding History

Colony Group’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-452	Closed	-$203K	–	547
2018 Q3	$203K	Buy	+452	New	+$178K	0.01%	485
2016 Q1	–	Sell	-50	Closed	-$5K	–	692
2015 Q4	$5K	Buy	+50	New	+$4.24K	﹤0.01%	667

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Colony Group's ABMD Position: Q4 2018 in Review

Colony Group sold out of Abiomed Inc (ABMD) in Q4 2018, closing a stake of 452 shares — an estimated $203K sold.

Colony Group first reported a position in ABMD in Q4 2015 and held it in 2 quarters. The position peaked at $203K in Q3 2018. 529 funds tracked by Wall St. Rank hold ABMD as of Q4 2018.

Colony Group reported no remaining Abiomed Inc position as of Q4 2018 after selling out during the quarter.
Colony Group sold 452 Abiomed Inc shares in Q4 2018, an estimated $203K.
Colony Group first reported a position in Abiomed Inc in Q4 2015 and held it in 2 quarters.
Colony Group's Abiomed Inc position peaked at $203K in Q3 2018.
529 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2018.

Based on Colony Group's 13F filing for Q4 2018, filed 15 Feb 2019.